Cigna Group (NYSE: CI)

Sector: Healthcare Industry: Healthcare Plans CIK: 0001739940
Market Cap 85.42 Bn
P/B 2.07
P/E 23.60
P/S 0.41
ROIC (Qtr) 10.49
Div Yield % 2.27
Rev 1y % (Qtr) 9.50
Total Debt (Qtr) 34.04 Bn
Debt/Equity (Qtr) 0.81
Add ratio to table...

About

Cigna Group, also known as CI, is a prominent player in the healthcare industry, dedicated to improving the health and well-being of individuals, families, and businesses. The company's operations span across various segments, including Evernorth Health Services and Cigna Healthcare, each offering a diverse range of health solutions and capabilities. Evernorth Health Services, a broad spectrum of independent and coordinated health solutions, is designed to enhance the healthcare system and promote healthier lives. This segment includes pharmacy...

Read more

Investment thesis

Bull case

  • Operating cash flow of 8.66B provides exceptional 21.50x coverage of minority interest expenses 403M, showing strong core operations.
  • Robust free cash flow of 7.44B exceeds capital expenditure of 1.23B by 6.06x, indicating strong organic growth funding capability.
  • Long-term investments of 18.48B provide solid 0.60x coverage of long-term debt 30.95B, indicating strategic financial planning.
  • Retained earnings of 47.03B provide full 1.52x coverage of long-term debt 30.95B, indicating strong internal capital position.
  • Tangible assets of 84.02B provide robust 6.13x coverage of other current liabilities 13.71B, indicating strong asset backing.

Bear case

  • Operating cash flow of 8.66B barely covers its investment activities of (4.18B), with a coverage ratio of -2.07, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 8.66B provides thin coverage of dividend payments of (1.60B) with a -5.42 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • High receivables of 35.92B relative to inventory of 5.63B (6.38 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Long-term investments of 18.48B represent a high 5.06x of fixed assets 3.65B, indicating potential overexposure to financial assets versus operational capabilities.
  • Retained earnings of 47.03B provide limited buffer against comprehensive income items of (2.80B), which is -16.80x, indicating elevated exposure to market risks.

Segments Breakdown of Revenue (2024)

Peer comparison

Companies in the Healthcare Plans
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 UNH Unitedhealth Group Inc 275.49 Bn 47.39 1.75 80.14 Bn
2 CVS CVS HEALTH Corp 101.72 Bn 15.33 0.40 79.95 Bn
3 CI Cigna Group 85.42 Bn 23.60 0.41 34.04 Bn
4 ELV Elevance Health, Inc. 77.22 Bn 13.64 0.39 32.05 Bn
5 HUM Humana Inc 25.29 Bn 14.38 0.43 12.92 Bn
6 CNC Centene Corp 20.34 Bn -3.05 0.10 17.40 Bn
7 MOH Molina Healthcare, Inc. 7.17 Bn 15.19 0.16 3.95 Bn
8 ALHC Alignment Healthcare, Inc. 3.90 Bn -187.18 1.07 0.33 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.69 1.08
EV to Cash from Ops. EV/CFO 9.34 3.83
EV to Debt EV to Debt 3.19 9.18
EV to EBIT EV/EBIT 21.00 -1,594.13
EV to EBITDA EV/EBITDA 9.19 15.88
EV to Free Cash Flow [EV/FCF] EV/FCF 10.68 8.41
EV to Market Cap EV to Market Cap 1.27 1.08
EV to Revenue EV/Rev 0.53 0.68
Price to Book Value [P/B] P/B 2.07 4.79
Price to Earnings [P/E] P/E 23.60 -5.08
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 3.84 1.21
Dividend Payout Ratio % Div Payout % (Qtr) 26.00 29.17
Dividend per Basic Share Div per Share (Qtr) 5.93 2.51
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 21.28 16.79
Interest Coverage Int. cover (Qtr) 6.38 -0.47
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 14.44 -30.05
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 2.33 18.06
Dividend Growth (1y) % Div 1y % (Qtr) 9.21 2.04
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 64.69 -108.29
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -3.86 -60.87
EBIT Growth (1y) % EBIT 1y % (Qtr) 96.41 -84.20
EBT Growth (1y) % EBT 1y % (Qtr) 141.24 -142.02
EPS Growth (1y) % EPS 1y % (Qtr) 112.30 -164.11
FCF Growth (1y) % FCF 1y % (Qtr) 43.46 111.09
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -1.80 7.06
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.70 2.20
Cash Payout Ratio Cash Payout (Qtr) 0.16 0.11
Cash Ratio Cash Ratio (Qtr) 0.11 0.48
Current Ratio Curr Ratio (Qtr) 0.83 1.46
Debt to Equity Ratio Debt/Equity (Qtr) 0.81 0.77
Interest Cover Ratio Int Coverage (Qtr) 6.38 -0.47
Times Interest Earned Times Interest Earned (Qtr) 6.38 -0.47
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 4.40 1.97
EBIT Margin % EBIT Margin % (Qtr) 3.35 1.42
EBT Margin % EBT Margin % (Qtr) 2.82 0.98
Gross Margin % Gross Margin % (Qtr) 9.60 14.54
Net Profit Margin % Net Margin % (Qtr) 2.30 0.45